ESMO | European Society for Medical Oncology + +... + +... +...

The Lancet Oncology in conversation with Andrea Necchi on TAR-200 plus cetrelimab as neoadjuvant therapy in patients with muscle-invasive bladder cancer September 29, 2025 • The Lancet Group https://thelancetoncology.buzzsprout.com/1391338/episodes/17897629-andrea-necchi-on-tar-200-plus-cetrelimab-as-neoadjuvant-therapy-in-patients-with-muscle-invasive-bladder-cancer?utm_campaign=infocusalerts-oncology&utm_medium=email&_hsenc=p2ANqtz--HYStAhFkvuQTyPJvWrp38OfZRCRQ59nbhalXmWLBd8Pdte6VLUk4BZbmTyyq_mF1d-z-puDwXTttokTfhXO6lHvAjlQ&_hsmi=389016090&utm_content=388871904&utm_source=hs_email ESMO | European Society for Medical Oncology https://www.thelancet.com/events/conferences/european-society-medical-oncology?dgcid=hubspot_email_infocusalerts-oncology_feature_esmo24&utm_campaign=infocusalerts-oncology&utm_medium=email&_hsenc=p2ANqtz-8DoznYeK68qeHJn0fRIKRqGi9wFWBMI0TsWn-MBjd7oz6ak6Jase1gcdAU1hxAkA_T6K4gCDyJZrWt0AjJ98roMhUGCg&_hsmi=389016090&utm_content=388871904&utm_source=hs_email Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trial https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00380-8/abstract?utm_campaign=infocusalerts-oncology&utm_medium=email&dgcid=hubspot_email_infocusalerts-oncology_feature&_hsenc=p2ANqtz--eNsFEJ-aGETe3ZAptDgmLxBsZg-Uhsy6Iw4aPpb3b1arCDgeUU18NG0G11q_PKkUW_fYrhUEqWC-PoJrdzrBDZjtWKw&_hsmi=389016090&utm_content=388871904&utm_source=hs_email Childhood cancer control in Asia https://www.thelancet.com/series-do/childhood-cancer-asia?dgcid=hubspot_email_infocusalerts-oncology_feature_childhoodcancerasia25&utm_campaign=infocusalerts-oncology&utm_medium=email&_hsenc=p2ANqtz-8riuit7Y___WhjW0PHzPEd77KcxtJxxF6_g2p4U0xMpFn6WtE53Yuj0ZE8NpVD4gFL9DTljMpHaQA0Ig387fOjUf4Hdw&_hsmi=389016090&utm_content=388871904&utm_source=hs_email Paediatric oncology https://www.thelancet.com/collections/paediatric-oncology?dgcid=hubspot_email_infocusalerts-oncology_feature&parent=001611&utm_campaign=infocusalerts-oncology&utm_medium=email&_hsenc=p2ANqtz--y5_q036hmKgON2thYn-KSwiKfVjXuvFuzuBElSWVRt_eRn3rPNWTK021siIVR1XEGUJI1lHKvZSJ2B3xVYUvN2_l17A&_hsmi=389016090&utm_content=388871904&utm_source=hs_email